Brook StarRay Wireless Controller Now Available — Native PS5 Support Meets Xbox-Style Control
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Scalare Launches EquityRoom, Adding a Subscription Revenue Stream to Its Founder Ecosystem
Megaannum Capital and Zhongke Xianxing Venture Capital Enter into Strategic Partnership
Airtripmaker Expands Business and First-class Flights Network to London, Amsterdam, Frankfurt, Tokyo, Sydney by Introducing Enhanced Coverage for Global Destinations as Part of Its Ongoing Growth Strategy
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) (“Faraday Future”, “FF” or “Company”), a…
GENEVA–(BUSINESS WIRE)–Textron Aviation announced today the newest Cessna Citation business jet in the legendary 560XL…
Global leaders in digital identity join forces to deliver user-controlled, shareable digital identity designed with…
Innovative partnership to drive scalability and smart development in Japan DALLAS–(BUSINESS WIRE)–CyrusOne, a leading global…
This article or press release has no online content. Please download the associated documents for…
REGULATED INFORMATION ALLOB Phase IIb topline results foreseen in July/August 2023Ongoing discussions for key partnerships…
TOKYO, May 22, 2023 – (JCN Newswire) – Tokyo Institute of Technology (Tokyo Tech), Tohoku…
HONG KONG, May 22, 2023 – (ACN Newswire) – A Hong Kong-based biopharmaceutical company dedicated…
These 48 solar plants will be able to produce more than 6,000 GWh of clean…
Labcorp Plans to Develop and Commercialize the Innovative Prostate Cancer Liquid Biopsy Test in the…
Companies collaborate to efficiently offer world-class support for Japan’s vast prospective user base Uniquely arms…
TOKYO, May 20, 2023 – (JCN Newswire) – Eisai Co., Ltd. and Biogen Inc. announced…
ZURICH, SWITZERLAND, May 22, 2023 – (ACN Newswire) – Neurimmune announced today that primary results…
HONG KONG, May 22, 2023 – (ACN Newswire) – A Hong Kong-based biopharmaceutical company dedicated…
Collaboration aims to bring further stability and security to the RHEL clone FORT MYERS, Fla.–(BUSINESS…
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8)…
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8)…
Dupixent is the first and only investigational biologic for COPD that has demonstrated a significant…
Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the…
– Study Led by John Mignone, M.D., Ph.D., Presented at the Heart Rhythm Society’s Annual…